New adenomyosis atlas reveals lesion-specific signals that may spare healthy uterine tissue
· Medical Xpressedited by Lisa Lock, reviewed by Andrew Zinin
Lisa Lock
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Researchers at the University of Liverpool have identified distinctive biological characteristics within adenomyosis lesions that could help pave the way for more targeted, less invasive treatments. The findings from a team based in Professor Dharani Hapangama's gynecology research group at the university provide new insights into the common but often underrecognized condition that affects up to 1 in 5 women of reproductive age. Despite its prevalence and significant impact on health and quality of life, adenomyosis has historically received limited attention in research and clinical practice.
Adenomyosis occurs when tissue similar to the lining of the womb grows deep into the muscle of the womb. It can cause heavy menstrual bleeding, severe pain and, in some cases, pregnancy and fertility complications.
Once thought to mainly affect older women, adenomyosis is now recognized as being common among younger women, including those who may wish to have children. Growing awareness of the condition has highlighted the need for improved diagnosis and more effective treatment options.
Current treatment options remain limited, largely consisting of hormone-based therapies that can prevent pregnancy or surgery to remove the womb. The lack of treatment choices reflects longstanding gaps in understanding the biological mechanisms that drive the disease.
The new study sought to understand how diseased tissue differs from healthy tissue within the uterus. By identifying the unique biological features of adenomyosis lesions, the research aims to support the development of treatments that target affected areas while preserving healthy uterine tissue.
To investigate these differences, researchers used spatial transcriptomics, an advanced technique that enables scientists to examine which genes are active in different cell types within their original tissue environment. Used for the first time to study human uterine tissue, this technique enabled direct comparisons between diseased and healthy tissue from the same uterus while preserving the tissue's structural integrity—a capability that previous methods lacked.
The findings, published in Science Advances, revealed that adenomyosis lesions possess a distinct biological "fingerprint," suggesting the possibility of developing treatments that specifically target lesions while leaving healthy tissue intact. Researchers also found that the lesions share characteristics with the deeper, more stable layer of the womb lining, which may help explain how the condition develops and persists over time.
In addition, the study identified evidence of ongoing inflammation and altered energy production within the diseased tissue. These processes may contribute to some of the symptoms commonly experienced by women with adenomyosis, including pain and heavy bleeding.
Using the molecular information generated by the study, researchers also identified a number of existing drugs and emerging medicines that could potentially reverse some of the biological changes observed in the lesions. While further investigation is needed, these findings may help guide the development of future treatment options that do not require major surgery.
Dr. Alison Maclean, NIHR clinical lecturer, who undertook this study during her MRC clinical research training fellowship, said, "This study provides important new insights into what is happening within adenomyosis lesions at a molecular level. By identifying the features that distinguish diseased tissue from healthy tissue, we are laying the groundwork for treatments that could directly target the condition while preserving the uterus and normal womb lining. Ultimately, our goal is to develop safe and effective therapies that help women avoid major surgery and protect their fertility where possible."
Publication details
Alison Maclean et al, Spatial transcriptomics uncovers the hybrid molecular identity, ciliated phenotype, and immune signature of adenomyosis lesions, Science Advances (2026). DOI: 10.1126/sciadv.aea6379
Journal information: Science Advances
Key medical concepts
AdenomyosisSpatial TranscriptomicsInflammation
Clinical categories
Obstetrics & gynecologyWomen's healthReproductive health Provided by University of Liverpool Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: New adenomyosis atlas reveals lesion-specific signals that may spare healthy uterine tissue (2026, July 3) retrieved 3 July 2026 from https://medicalxpress.com/news/2026-07-adenomyosis-atlas-reveals-lesion-specific.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.